当前位置: X-MOL 学术Gen. Thorac. Cardiovasc. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hybrid treatment of a giant coronary artery aneurysm in a patient with immunoglobulin G4-related disease
General Thoracic and Cardiovascular Surgery ( IF 1.1 ) Pub Date : 2021-06-08 , DOI: 10.1007/s11748-021-01668-4
Yuji Kamikawa 1, 2 , Takeki Ohashi 1 , Masao Tadakoshi 1 , Akinori Kojima 1 , Hirotaka Yamauchi 1 , Kaoru Hioki 1 , Takanori Hishikawa 1 , Souichirou Kageyama 1
Affiliation  

A 62-year-old man was diagnosed with a giant coronary artery aneurysm associated with immunoglobulin G4 (IgG4)-related disease. He had previously undergone two thoracic operations with sternotomies and abdominal aortic aneurysm repair for IgG4-related aortopathy. We opted for hybrid open and endovascular repair to reduce risk and avoid complications of a resternotomy and extracorporeal circulation. This first successful case of hybrid repair of a giant coronary artery aneurysm shows that the procedure is safe and feasible in patients with IgG4-related vasculopathy. It is critical to carefully monitor these patients for the occurrence of new IgG4-related aneurysms and other manifestations of vasculopathy.



中文翻译:

免疫球蛋白G4相关疾病患者巨大冠状动脉瘤的混合治疗

一名 62 岁男性被诊断出患有与免疫球蛋白 G4 (IgG4) 相关疾病相关的巨大冠状动脉瘤。他之前曾因 IgG4 相关的主动脉病接受过两次胸骨切除术和腹主动脉瘤修复术。我们选择了混合开放和血管内修复,以降低风险并避免再切开术和体外循环的并发症。巨大冠状动脉瘤混合修复的首个成功案例表明,该手术在 IgG4 相关血管病变患者中是安全可行的。仔细监测这些患者是否出现新的 IgG4 相关动脉瘤和其他血管病变表现至关重要。

更新日期:2021-06-08
down
wechat
bug